The White House on Tuesday responded to concerns voiced by a Moderna executive who suggested the current vaccines slotted to fight the coronavirus will not be enough to counter the new omicron ...

Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

Stock markets around the world have fallen after the boss of Moderna cast doubts on the effectiveness of vaccines against the new Omicron Covid variant. Stephane Bancel told the Financial Times he ...

COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Moderna has begun testing an Omicron-specific COVID-19 booster in healthy adults. The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor ...

US company Moderna is planning to begin trials of its own Omicron-specific shot soon. Oxford University and AstraZeneca have also started working on a new version of their vaccine. Vaccine ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...

Both Moderna and Pfizer-BioNTech manufacture the ... "At the height of the Omicron wave, we still saw a lot of children being ...